查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1598481

毒理学药物筛检市场：按产品、测试和应用 - 全球预测 2025-2030

Toxicology Drug Screening Market by Product (Animal Models, Instruments, Reagents & Consumables), Testing (In Silico, In Vitro, In Vivo), Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年毒理学药物筛检市值为270.7亿美元，预计2024年将达到305.9亿美元，复合年增长率为13.38%，到2030年将达到652.2亿美元。

毒理学药物筛检市场被定义为专注于检测生物样本中药物及其代谢物的存在和浓度的医学诊断领域。由于药物滥用的增加、职场、体育和法律环境中常规药物检测的需要以及对新药的需求不断增长，该市场至关重要。应用范围包括医疗保健、体育、刑事司法和职场安全，最终用途包括医院、实验室、执法和家庭测试。主要成长动力包括药物滥用的增加、强制药物筛检的更严格法规、检测套组的技术进步以及对职场药物检测的日益关注。开拓新市场的机会在于拓展认知度和渗透率仍较低的新兴市场，以及开发快速、非侵入性的检测方法。此外，利用人工智慧和机器学习进行毒理学测试资料分析具有巨大潜力。

主要市场统计
基准年[2023] 270.7亿美元
预测年份 [2024] 305.9亿美元
预测年份 [2030] 652.2亿美元
复合年增长率（%） 13.38%

相反，市场面临测试设备高成本、影响测试准确性的误报、隐私问题和监管复杂性等限制。此外，一些地区围绕药物测试的耻辱可能会阻碍市场成长。创新可以集中在开发更实惠、更准确的检测套组、小型化护理点设备以及加快测试过程。特别是，对唾液和呼吸分析等非侵入性测试方法的研究是一个有前途的途径。市场竞争非常激烈，现有企业专注于技术进步和策略联盟，而新参与企业可能会开拓个人化医疗或特定药物类别等利基市场。为了方便而进行远端和家庭测试的持续趋势进一步凸显了该市场不断发展的性质。因此，寻求成长的公司应该投资于研发、策略伙伴关係关係以及适合当地需求的市场扩大策略。

市场动态：快速发展的毒理学药物筛检市场的关键市场洞察

毒理学药物筛检市场正因供需的动态交互作用而转变。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 职场药物检测的增加和床边检测 (POCT) 设备的高普及率
    • 增加高阶药物筛检设备、试剂和套件的可用性
    • 增加政府毒理学测试支出
  • 市场限制因素
    • 毒理药物筛检试验高成本
  • 市场机会
    • 先进毒理学药物筛检试验简介
    • 食品、饮料和化学工业越来越多地采用毒理学药物筛检
  • 市场挑战
    • 与毒理学药物筛检相关的更长的样本测试时间

波特五力：驾驭毒理学药物筛检市场的策略工具

波特的五力架构是了解毒理学药物筛检市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解毒理学药物筛检市场的外部影响

外部宏观环境因素在塑造毒理学药物筛检市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助企业预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解毒理学药物筛检市场的竞争格局

毒理学药物筛检市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵毒理学药物筛检市场供应商的绩效评估

FPNV定位矩阵是评估毒理学药物筛检市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了毒理学药物筛检市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，毒理学药物筛检市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 增加职场药物检测的实施和就地检验(POCT) 设备的广泛采用
      • 提高高性能药物筛检仪器、试剂和套件的可用性
      • 增加政府在毒性测试方面的支出
    • 抑制因素
      • 毒理药物筛检试验高成本
    • 机会
      • 先进毒理学药物筛检试验简介
      • 食品饮料和化学工业越来越多地采用毒理学药物筛检
    • 任务
      • 与毒理学药物筛检相关的样本测试週转时间增加
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章毒理学药物筛检市场：副产品

  • 动物模型
  • 装置
  • 试剂/耗材
  • 软体

第七章 毒理学药物筛检试验市场

  • 模拟
  • 体外
  • In vivo

第八章毒理学药物筛检市场：依应用分类

  • 发育和生殖毒性
  • 内分泌干扰
  • 免疫毒性
  • 全身毒性

第九章美洲毒理学药物筛检市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太毒理学药物筛检市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲毒理学药物筛检市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories Inc.
  • Charles River Laboratories International, Inc.
  • Clinical Reference Laboratory, Inc.
  • Enzo Life Sciences, Inc.
  • Eurofins Scientific SE
  • GE Healthcare
  • Laboratory Corporation of America Holdings
  • Promega Corporation
  • Quest Diagnostics
  • Selvita SA
  • Thermo Fisher Scientific Inc.
  • Waters Corporation
  • Wuxi AppTec Co., Ltd.
Product Code: MRR-AD517FAA7D9A

The Toxicology Drug Screening Market was valued at USD 27.07 billion in 2023, expected to reach USD 30.59 billion in 2024, and is projected to grow at a CAGR of 13.38%, to USD 65.22 billion by 2030.

The toxicology drug screening market is defined as the segment of medical diagnostics focused on detecting the presence and concentration of drugs and their metabolites in biological samples. This market is crucial due to rising substance abuse, the need for routine drug testing in workplaces, sports, legal environments, and the growing demand for new drugs. The applications extend to healthcare, sports, criminal justice, and workplace safety, while the end-use scope largely includes hospitals, laboratories, law enforcement agencies, and in-home testing. Key growth drivers include the increasing prevalence of drug abuse, stringent regulations mandating drug screening, technological advancements in testing kits, and a growing emphasis on workplace drug testing. Emerging opportunities lie in expanding into emerging markets where awareness and adoption are still nascent and developing rapid, non-invasive testing methods. Additionally, leveraging AI and machine learning for data analysis in toxicology screens offers significant potential.

KEY MARKET STATISTICS
Base Year [2023] USD 27.07 billion
Estimated Year [2024] USD 30.59 billion
Forecast Year [2030] USD 65.22 billion
CAGR (%) 13.38%

Conversely, the market faces limitations such as the high cost of testing equipment, false positives affecting test accuracy, privacy concerns, and regulatory complexities. Moreover, the stigma associated with drug testing in certain regions can hinder market growth. Innovations could focus on developing more affordable and accurate testing kits, miniaturized point-of-care devices, and improving the speed of testing processes. Particularly, research into non-invasive testing methods like saliva or breath analysis offers promising avenues. The market is competitive, with established players focusing on technological advancements and strategic partnerships, while new entrants might explore niche areas such as personalized medicine or specific drug categories. The continued trend toward remote and home testing due to its convenience further underlines the nature of this evolving market. Therefore, companies aiming for growth should invest in research and development, strategic partnerships, and market expansion strategies tailored to localized needs.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Toxicology Drug Screening Market

The Toxicology Drug Screening Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing practice of workplace drug testing and high penetration of point of care testing (POCT) devices
    • Growing availability of high-end drug screening instruments, reagent and kits
    • Rising government expenditure on toxicity testing
  • Market Restraints
    • High Cost of toxicology drug screening tests
  • Market Opportunities
    • Introduction of advanced toxicology drug screening tests
    • Rise in adoption of toxicology drug screening in the food and beverage industry, and chemical industry
  • Market Challenges
    • Longer time for sample testing associated with toxicology drug screening

Porter's Five Forces: A Strategic Tool for Navigating the Toxicology Drug Screening Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Toxicology Drug Screening Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Toxicology Drug Screening Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Toxicology Drug Screening Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Toxicology Drug Screening Market

A detailed market share analysis in the Toxicology Drug Screening Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Toxicology Drug Screening Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Toxicology Drug Screening Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Toxicology Drug Screening Market

A strategic analysis of the Toxicology Drug Screening Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Toxicology Drug Screening Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., Bio-Rad Laboratories Inc., Charles River Laboratories International, Inc., Clinical Reference Laboratory, Inc., Enzo Life Sciences, Inc., Eurofins Scientific SE, GE Healthcare, Laboratory Corporation of America Holdings, Promega Corporation, Quest Diagnostics, Selvita S.A., Thermo Fisher Scientific Inc., Waters Corporation, and Wuxi AppTec Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Toxicology Drug Screening Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Animal Models, Instruments, Reagents & Consumables, and Software.
  • Based on Testing, market is studied across In Silico, In Vitro, and In Vivo.
  • Based on Application, market is studied across Developmental & Reproductive Toxicity, Endocrine Disruption, Immunotoxicity, and Systemictoxicity.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing practice of workplace drug testing and high penetration of point of care testing (POCT) devices
      • 5.1.1.2. Growing availability of high-end drug screening instruments, reagent and kits
      • 5.1.1.3. Rising government expenditure on toxicity testing
    • 5.1.2. Restraints
      • 5.1.2.1. High Cost of toxicology drug screening tests
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of advanced toxicology drug screening tests
      • 5.1.3.2. Rise in adoption of toxicology drug screening in the food and beverage industry, and chemical industry
    • 5.1.4. Challenges
      • 5.1.4.1. Longer time for sample testing associated with toxicology drug screening
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Toxicology Drug Screening Market, by Product

  • 6.1. Introduction
  • 6.2. Animal Models
  • 6.3. Instruments
  • 6.4. Reagents & Consumables
  • 6.5. Software

7. Toxicology Drug Screening Market, by Testing

  • 7.1. Introduction
  • 7.2. In Silico
  • 7.3. In Vitro
  • 7.4. In Vivo

8. Toxicology Drug Screening Market, by Application

  • 8.1. Introduction
  • 8.2. Developmental & Reproductive Toxicity
  • 8.3. Endocrine Disruption
  • 8.4. Immunotoxicity
  • 8.5. Systemictoxicity

9. Americas Toxicology Drug Screening Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Toxicology Drug Screening Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Toxicology Drug Screening Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Agilent Technologies, Inc.
  • 3. Bio-Rad Laboratories Inc.
  • 4. Charles River Laboratories International, Inc.
  • 5. Clinical Reference Laboratory, Inc.
  • 6. Enzo Life Sciences, Inc.
  • 7. Eurofins Scientific SE
  • 8. GE Healthcare
  • 9. Laboratory Corporation of America Holdings
  • 10. Promega Corporation
  • 11. Quest Diagnostics
  • 12. Selvita S.A.
  • 13. Thermo Fisher Scientific Inc.
  • 14. Waters Corporation
  • 15. Wuxi AppTec Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. TOXICOLOGY DRUG SCREENING MARKET RESEARCH PROCESS
  • FIGURE 2. TOXICOLOGY DRUG SCREENING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. TOXICOLOGY DRUG SCREENING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. TOXICOLOGY DRUG SCREENING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. TOXICOLOGY DRUG SCREENING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. TOXICOLOGY DRUG SCREENING MARKET DYNAMICS
  • TABLE 7. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY ANIMAL MODELS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY IN SILICO, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY IN VITRO, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY IN VIVO, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DEVELOPMENTAL & REPRODUCTIVE TOXICITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY ENDOCRINE DISRUPTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY IMMUNOTOXICITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SYSTEMICTOXICITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. TOXICOLOGY DRUG SCREENING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 149. TOXICOLOGY DRUG SCREENING MARKET, FPNV POSITIONING MATRIX, 2023